Author(s): Lata Kothapalli, Harshali Lunkad, Asha Thomas, Rahul Tupe

Email(s): latapk19@gmail.com

DOI: 10.5958/0974-360X.2020.00425.4   

Address: Lata Kothapalli*, Harshali Lunkad, Asha Thomas, Rahul Tupe
Department of Pharmaceutical Chemistry, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 18, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 5,     Year - 2020


ABSTRACT:
Deflazacort is an oxazoline derivative of prednisolone with anti-inflammatory and immunosuppressive activity. The present study describes the development of HPTLC method based on systematic design of experiment followed by validation of the method for the analysis of Deflazacort in bulk and tablet dosage form. Systematic optimization was performed employing Box-Behnken design (BBD). Mobile phase ratio, band width, solvent front were selected as the critical method parameters (CMPs) for initial screening studies. Search for optimum chromatographic conditions was carried out with numerical and graphical optimization and the design space was generated with peak area and retention factor as critical analytical attributes (CAAs). Based on the predicted optimized chromatographic condition, aluminium plates pre-coated with silica gel 60 F254 as the stationary phase and toluene: methanol: glacial acetic acid (8.3:1.2:0.5% v/v/v) as the mobile phase. Quantification was achieved based on densitometry analysis of Deflazacort over the concentration range of 120-720 ng/band at 243 nm. The method yielded compact and well-resolved bands at Rf of 0.43 ± 0.03 for Deflazacort. The developed method was validated according to ICH guidelines. Further validated method was used to study degradation of Deflazacort when exposed to stress conditions like acidic and alkaline hydrolysis, oxidative and photolytic degradation. Developed validated method applied for forced degradation studies make the method highly efficient for the routine analysis of marketed tablet formulations.


Cite this article:
Lata Kothapalli, Harshali Lunkad, Asha Thomas, Rahul Tupe. Design of Experiment Based Validated HPTLC Method for Analysis of Deflazacort in Tablet Formulation. Research J. Pharm. and Tech 2020; 13(5):2366-2372. doi: 10.5958/0974-360X.2020.00425.4

Cite(Electronic):
Lata Kothapalli, Harshali Lunkad, Asha Thomas, Rahul Tupe. Design of Experiment Based Validated HPTLC Method for Analysis of Deflazacort in Tablet Formulation. Research J. Pharm. and Tech 2020; 13(5):2366-2372. doi: 10.5958/0974-360X.2020.00425.4   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-5-55


REFERENCES:
1.    O'Neil MJ. The Merck Index Encyclopaedia of chemicals, drugs and biological. 14thEd. New York: Merck andco.2006; 848.    
2.    Hirata H, Kasama T, Sawai Y, Fike RR. Simultaneous determination of deflazacort metabolites II and III, cortisol, cortisone, prednisolone and prednisone in human serum by reverse-phase high-performance liquid chromatography. Journal of Chromatography B.1994; 658; 55-61.
3.    Correa GM, Belle LP, Bajerski L, Borgmann SHM, Cardoso SG. Development and Validation of a Reversed-Phase HPLC Method for the Determination of Deflazacort in Pharmaceutical Dosage Forms. Chromatographia. 2007; 65(9–10): 591–594.
4.    Paulino AS, Rauber G, Deobald AM, Paulino N, Sawaya AC, Eberlin MN, et al. Isolation and Characterization of a Degradation Product of Deflazacort. Pharmazie;2012 :495–99.
5.    Ramesh RR. Development and validation of deflazacort drug in pharmaceutical dosage form. International Journal of Science and Technology. 2012; 1 (1): 29-34.
6.    Scremin A, Piazzon M, Silva M A, Kuminek G, Correa GM, Paulino N, Spectrophotometric and HPLC determination of deflazacort in pharmaceutical dosage forms. Brazilian Journal Of Pharmaceutical Science.2010; 46(2):1-7.
7.    More S, Yadav SS, Shinde SS, Rao JR. Estimation of deflazacort in pharmaceutical dosage form. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5(4):166-171.
8.    Sharma Y, Jain N, Jain H, Jain P, Jain A, Development and validation of RP- HPLC method of deflazacort for stability indicating assay. International Journal of Pharmacy. 2014; 4(2): 117-123.
9.    Chougule,DD Naikwade NS. Development and Validation of High Performance Liquid Chromatographic Method for Estimation of Deflazacort in Pharmaceutical Formulation. Asian J. Research Chem. 4(1): January 2011; Page 140-142
10.    Patel SA, Patel NJ. Validated Spectrophotometric Methods for Determination of Deflazacort in Tablet Dosage Form. Asian Journal of Pharmacy and Life Science.2011;1 (3): 216-223.
11.    Patel SA. Development and validation of spectrophotometric methods for estimation of deflazacort in pharmaceutical dosage form.  International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(5): 269-272.
12.    Deshmukh R, Sharma L, Tekade M, Kesharwani P, Trivedi P, Tekade RK., Forced degradation behaviour of glucocorticoid deflazacort by UPLC: Isolation, Identification An Characterization Of Degradants By FTIR, NMR And Mass Analysis. The Journal of Biomedical Research. 2016; 30(2):149-161.
13.    Karthikeyan S, Singh AS, Puthli S. LC-MS / MS method for the quantification of deflazacort metabolite in human plasma : Development, validation and application to a pharmacokinetic study. Journal of Drug Delivery and Therapeutics. 2013; 3(2): 75-82.
14.    Patel SA, Patel NJ. High Performance Thin Layer Chromatographic Method for Estimation of Deflazacort in Tablet. Journal of Applied Pharmaceutical Science. 2011: 1(7): 94–98.
15.    Gandhi SP , Dewani MG, Borole TC, Damle MC. Development and Validation of Stability Indicating HPTLC Method for Determination of Trandolapril as Bulk Drug. Asian J. Research Chem. 4(3): March 2011; Page 437-440.
16.    International Conference on Harmonization (ICH). Text on validation of analytical procedure: methodology: Q2 (R1), 2005.
17.    Patil AS, Shirikhedkar AA. Application of Quality by Design in the Development of HPTLC Method for Estimation of Anagliptin in Bulk and in- House Tablets. Eurasian Journal of Analytical Chemistry .2017; 12(5): 443–58.
18.    Rajkotwala RS, Sirajuddin SS., Dedania ZR, Vijendraswamy SM. QbD approach to analytical method development and validation of piracetam by HPLC. World journal of pharmacy and pharmaceutical sciences.2016; 5(5):1771-1784.
19.    Sandhu P, Beg S, Singh B. QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen. Journal of Chromatographic Science. 2016; 1–12.
20.    Muheem A, Shakeel F, Zafar S, Jahangir MA, Warsi MH, Jain G, et al. Development and validation of stability indicating liquid chromatographic (RP-HPLC) method for estimation of ubidecarenone in bulk drug and formulations using quality by design (QBD) approach. Brazilian Journal of Pharmaceutical Sciences.2017; 53(4):1-11.
21.    Jadhav ML, Tambe SR. Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Propafenone Hydrochloride in Tablet Dosage Form. Chromatography Research International.2013; 1-9.
22.    Panda SS, Beg S, Bera R, Rath J. A Mini Review: Implementation of Quality by Design Approach for Developing Chromatographic Methods with Enhanced Performance.2016; 2 (6): 2-4.
23.    Nanda,RK, Bhagwat,VV,Potawale, SE, Hamane.SC Development and Validation of A HPTLC Method for Simultaneous Densitometric Analysis of Cefixime and Potassium Clavulanate as the Bulk Drugs and in the Tablet Dosage Form. Asian J. Research Chem. 3(4): Oct. - Dec. 2010; Page 998-1001.
24.    Lata P. Kothapalli, Karan S. Vighne, Rabindra K. Nanda, Asha B. Thomas. Development and Validation of a Stability Indicating HPTLC Method for Estimation of Artemether in Bulk and Formulated dosage form. Asian J. Research Chem. 8(10): October 2015; Page 635-642.
25.    Lata P. Kothapalli, Madhav S. Panchaware, Rabindra K. Nanda, Asha B.Thomas. Stability-Indicating HPTLC Method for Simultaneous Determination of Lisinopril Anhydrate and S-Amlodipine Besylate in Pharmaceutical Dosage Form. Asian J. Research Chem. 5(8): August, 2012; Page 1061-1066.
26.    Roge, AB  Tarte, PS Kumare, MM, Shendarkar, GR, Vadvalkar. SM, Forced Degradation Study: An Important Tool in Drug Development. Asian J. Pharm. Res. 3(4): Oct. - Dec.2013; Page 198-201.
27.    Ingole LR. Development of Stability Indicating RP-HPLC Method for Estimation of Clemastine Fumarate and its Pharmaceutical Dosage Form. Res. J. Pharma. Dosage Forms and Tech.2019; 11(2): 87-94.
28.    Kothapalli,L P., Shahane, RR, Nanda,RK Thomas, AB. Development and validation of stability indicating HPTLC method for simultaneous estimation of Domperidone maleate and Naproxen sodium in pharmaceutical formulations. Asian J. Research Chem. 2016; 9(7): 350-356.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available